24 July 2017 by Norbert Voelkel

Norbert Voelkel - A study of Ubenimex in patients with PAH, the 'LIBERTY' trial

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg